Treace Medical Concepts
TMCI
91 hedge funds and large institutions have $590M invested in Treace Medical Concepts in 2022 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 40 increasing their positions, 23 reducing their positions, and 10 closing their positions.
80% more first-time investments, than exits
New positions opened: 18 | Existing positions closed: 10
78% more capital invested
Capital invested by funds: $332M → $590M (+$259M)
74% more repeat investments, than reductions
Existing positions increased: 40 | Existing positions reduced: 23
10% more funds holding
Funds holding: 83 → 91 (+8)
6.51% more ownership
Funds ownership: 41.78% → 48.3% (+6.5%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Janus Henderson Group
London,
United Kingdom
|
+$12.9M |
| 2 |
PA
Perceptive Advisors
New York
|
+$12.8M |
| 3 |
SPPAM
Summit Partners Public Asset Management
Boston,
Massachusetts
|
+$9.38M |
| 4 |
BlackRock
New York
|
+$8.23M |
| 5 |
Russell Investments Group
London,
United Kingdom
|
+$7.31M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RJFSA
Raymond James Financial Services Advisors
St. Petersburg,
Florida
|
-$6.06M |
| 2 |
William Blair Investment Management
Chicago,
Illinois
|
-$4.88M |
| 3 |
Millennium Management
New York
|
-$4.39M |
| 4 |
NCGI
Next Century Growth Investors
Plymouth,
Minnesota
|
-$3.21M |
| 5 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
-$2.57M |
TMCI Hedge Fund Activity: Q3 2022 in Review
91 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Treace Medical Concepts (TMCI) for Q3 2022, worth a combined $590M — up 78% from $332M a quarter earlier.
Buyers outnumbered sellers: 18 funds opened new TMCI positions and 10 closed out — a net gain of 8 holders — while 40 added to existing stakes and 23 trimmed.
The largest buyer was Janus Henderson Group, adding an estimated $12.9M. The largest seller was Raymond James Financial Services Advisors, exiting entirely with an estimated $6.06M sold.
- 91 institutional investors held Treace Medical Concepts (TMCI) as of Q3 2022, up from 83 in Q2 2022.
- Funds reported $590M of Treace Medical Concepts stock for Q3 2022, up 78% quarter-over-quarter.
- 18 funds opened new Treace Medical Concepts positions in Q3 2022 and 10 closed out, a net change of +8 holders.
- The largest Treace Medical Concepts buyer in Q3 2022 was Janus Henderson Group, an estimated $12.9M added.
- The largest Treace Medical Concepts seller in Q3 2022 was Raymond James Financial Services Advisors, an estimated $6.06M sold.
Based on aggregated 13F filings for Q3 2022.